Work

Effect of an Intensive Weight-Loss Lifestyle Intervention on Kidney Function: A Randomized Controlled Trial

Year: 2021
Type: article
Study design: Clinical Trial
Abstract: INTRODUCTION: Large randomized trials testing the effect of a multifactorial weight-loss lifestyle intervention including Mediterranean diet (MedDiet) on renal function are lacking. Here, we evaluated the 1-year efficacy of an intensive weight-loss intervention with an energy-reduced MedDiet (erMedDiet) plus increased physical activity (PA) on renal function. METHODS: Randomized controlled "PREvención con DIeta MEDiterránea-Plus" (PREDIMED-Plus) trial is conducted in 23 Spanish centers comprising 208 primary care clinics. Overweight/obese (n = 6,719) adults aged 55-75 years with metabolic syndrome were randomly assigned (1:1) to an intensive weight-loss lifestyle intervention with an erMedDiet, PA promotion, and behavioral support (intervention) or usual-care advice to adhere to an energy-unrestricted MedDiet (control) between September 2013 and December 2016. The primary outcome was 1-year change in estimated glomerular filtration rate (eGFR). Secondary outcomes were changes in urine albumin-to-creatinine ratio (UACR), incidence of moderately/severely impaired eGFR (<60 mL/min/1.73 m2) and micro- to macroalbuminuria (UACR ≥30 mg/g), and reversion of moderately (45 to <60 mL/min/1.73 m2) to mildly impaired GFR (60 to <90 mL/min/1.73 m2) or micro- to macroalbuminuria. RESULTS: After 1 year, eGFR declined by 0.66 and 1.25 mL/min/1.73 m2 in the intervention and control groups, respectively (mean difference, 0.58 mL/min/1.73 m2; 95% CI: 0.15-1.02). There were no between-group differences in mean UACR or micro- to macroalbuminuria changes. Moderately/severely impaired eGFR incidence and reversion of moderately to mildly impaired GFR were 40% lower (HR 0.60; 0.44-0.82) and 92% higher (HR 1.92; 1.35-2.73), respectively, in the intervention group. CONCLUSIONS: The PREDIMED-Plus lifestyle intervention approach may preserve renal function and delay CKD progression in overweight/obese adults.
Institutions: Instituto de Salud Carlos III, Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition, Institut de Recerca Biomèdica Catalunya Sud, Centro de Investigación Biomédica en Red, Hospital Universitari Sant Joan de Reus, Universitat Rovira i Virgili, Navarre Institute of Health Research, Universidad de Navarra, Universitat de València, Municipal Institute for Medical Research, Hospital del Mar Research Institute, Health Research Institute of the Balearic Islands, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Hospital Universitario Araba, Instituto de Investigación Biomédica de Málaga, Universidad de Málaga, Madrid Institute for Advanced Studies, IMDEA Food, Universidad de Las Palmas de Gran Canaria, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Bellvitge University Hospital, Universitat de les Illes Balears, Instituto Maimónides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofía, University of Córdoba, Universidad de Granada, Universidad de Jaén, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Universidad de León, Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas, Hospital Clínic de Barcelona, Hospital Universitario Fundación Jiménez Díaz, Harvard University
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3109392941
FWCI: 4.684
Cites: 44
Cited by: 53
Related to: 10